Company news: Bod; Neurotech International; Emyria; Creso Pharma by Martin Lane August 23, 2022August 23, 2022 Bod Australia Bod has been awarded US Hemp Authority Certification for its CBD extract and CBD […]
Neurotech International announces breakthrough results from autism study by Martin Lane July 8, 2022July 8, 2022
Neurotech results could lead to treatment alternatives for range of neuroinflammatory disorders by Martin Lane June 10, 2022June 10, 2022
Neurotech secures cultivation partnership with CannaPacific by Martin Lane March 10, 2021March 10, 2021
Neurotech extends licence to include all neurological disorders by Martin Lane March 3, 2021March 3, 2021
Neurotech International completes in-vitro studies of its proprietary cannabis leads, clinical trials to follow by Martin Lane December 22, 2020December 22, 2020
Neurotech International’s new chairman to focus on cannabis treatments for cognitive disorders by Emma Castle November 2, 2020November 2, 2020
